Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Kent

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Blood|February 3, 2023
Resolving the hematopoietic stem cell state by linking functional and molecular assaysMaria Jassinskaja, Monika Gonka, David G Kent
Cancer Research|September 2, 2011
The First AACR special conference on stem cells, development, and cancer: some of these cells are not like the othersDavid G Kent, Jennifer C Lin, Geraldine Aubert
Hemasphere|November 2, 2020
Response to Collinson et al. CommentMiriam Belmonte, Nina F Øbro, David G Kent
Current Protocols in Stem Cell Biology|August 18, 2016
Isolation and Assessment of Single Long-Term Reconstituting Hematopoietic Stem Cells from Adult Mouse Bone MarrowDavid G Kent, Brad J Dykstra, Connie J Eaves
The New England Journal of Medicine|May 7, 2015
Effect of mutation order on myeloproliferative neoplasmsDavid G Kent, Christina A Ortmann, Anthony R Green
Blood|June 21, 2024
Emerging genetic technologies informing personalized medicine in Shwachman-Diamond syndrome and other inherited BMF disordersAlyssa H Cull, David G Kent, Alan J Warren
Stem Cell Reports|June 24, 2020
Survey Says: "COVID-19 Lockdown Hits Young Faculty and Clinical Trials"David G Kent, David J H F Knapp, Nagarajan Kannan
Disease Models & Mechanisms|May 12, 2011
Mouse models of myeloproliferative neoplasms: JAK of all gradesJuan Li, David G Kent, Edwin Chen, et al.
Experimental Hematology|September 10, 2014
Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasmsJanine Prick, Gerald de Haan, Anthony R Green, et al.
Experimental Hematology|March 22, 2016
Understanding hematopoiesis from a single-cell standpointKonstantinos D Kokkaliaris, Daniel Lucas, Isabel Beerman, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Blood|February 3, 2023
Resolving the hematopoietic stem cell state by linking functional and molecular assaysMaria Jassinskaja, Monika Gonka, David G Kent
Cancer Research|September 2, 2011
The First AACR special conference on stem cells, development, and cancer: some of these cells are not like the othersDavid G Kent, Jennifer C Lin, Geraldine Aubert
Hemasphere|November 2, 2020
Response to Collinson et al. CommentMiriam Belmonte, Nina F Øbro, David G Kent
Current Protocols in Stem Cell Biology|August 18, 2016
Isolation and Assessment of Single Long-Term Reconstituting Hematopoietic Stem Cells from Adult Mouse Bone MarrowDavid G Kent, Brad J Dykstra, Connie J Eaves
The New England Journal of Medicine|May 7, 2015
Effect of mutation order on myeloproliferative neoplasmsDavid G Kent, Christina A Ortmann, Anthony R Green
Blood|June 21, 2024
Emerging genetic technologies informing personalized medicine in Shwachman-Diamond syndrome and other inherited BMF disordersAlyssa H Cull, David G Kent, Alan J Warren
Stem Cell Reports|June 24, 2020
Survey Says: "COVID-19 Lockdown Hits Young Faculty and Clinical Trials"David G Kent, David J H F Knapp, Nagarajan Kannan
Disease Models & Mechanisms|May 12, 2011
Mouse models of myeloproliferative neoplasms: JAK of all gradesJuan Li, David G Kent, Edwin Chen, et al.
Experimental Hematology|September 10, 2014
Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasmsJanine Prick, Gerald de Haan, Anthony R Green, et al.
Experimental Hematology|March 22, 2016
Understanding hematopoiesis from a single-cell standpointKonstantinos D Kokkaliaris, Daniel Lucas, Isabel Beerman, et al.
Pageof 9